Kendra Adams
Director of Finance/CFO at C4 THERAPEUTICS, INC.
Net worth: 900 788 $ as of 2024-02-28
Profile
Presently, Kendra R.
Adams occupies the position of Chief Financial Officer & Treasurer of C4 Therapeutics, Inc.
In the past Ms. Adams held the position of Director-Investor Relations of ARIAD Pharmaceuticals, Inc. and VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc.
She received an undergraduate degree from Hamilton College (New York).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.12% | 2024-03-06 | 82,039 ( 0.12% ) | 900 788 $ | 2024-02-28 |
Kendra Adams active positions
Companies | Position | Start |
---|---|---|
C4 THERAPEUTICS, INC. | Director of Finance/CFO | 2023-09-17 |
Former positions of Kendra Adams
Companies | Position | End |
---|---|---|
AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Kendra Adams
Hamilton College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |